New biosensor in seatbelt monitors drivers' condition
Scientists from the National University of Singapore and Tsinghua University have developed a new biosensor that can monitor the condition of drivers and pilots. It has been built into the seat belt.
The new sensor is designed to cope with problems caused by vibrations in vehicles. It uses special materials and conductive filaments that help it pick up biosignals even through clothing. The bio-sensor is able to monitor heartbeat and breathing without contact with the body.
Studies have shown that the device works successfully in traffic conditions. During testing in an airplane simulator and in real cars, the researchers confirmed the high efficiency of the sensor. It successfully detected cardiopulmonary signals for 1.5 hours.
In addition, the biosensor demonstrated its effectiveness in tracking the subjects' heart rate during sleep and wakefulness in a simulator. This opens up the potential for continuous monitoring of physiologic parameters under challenging conditions.
In the future, scientists plan to improve the sensor and test it in additional scenarios
Medicine
MedTech
8
0
0
Comments
Recommended
Pavel Ryzhikh
79 subscribers
2 months ago
Subscribe
US has developed a patch to transfer tactile sensations from video games
American scientists from Northwestern University have presented an innovative gadget that allows users to feel tactile sensations from video games on their own body. The new patch is made of a silicone plate and is equipped with 19 highly efficient actuators.
The device is capable of generating a variety of tactile effects, from light vibration to intense twisting. This greatly increases the leve
Show more
Medicine
Biotech
13
1
0
Stephanie Turner
14 subscribers
2 months ago
Subscribe
Biotech startup 23andMe lays off 40% of employees and stops drug development
- DNA testing startup to lay off 40% of employees
- Layoffs could affect 200+ employees at 23andMe
- The startup is trying to stabilize a loss-making business
- Also, 23andMe will close its drug development business
- It was already testing two drugs on humans
- 23andMe will try to sell promising drugs
- Previously, drug development was its key bet
- 23andMe still wants to license its data
- It's
All trademarks, logos, and brands are the property of their respective owners. All company, product, and service names used in this website are for identification purposes only.